USPTO serial 79264599
PAPITROL
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 29, 2020
- Examiner
- O'BRIEN, JENNIFER LYNN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with PAPITROL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*
Plus Government fees of $325
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Leigh Ann Lindquist
Leigh Ann Lindquist Sughrue Mion, PLLC2000 Pennsylvania Avenue NW, Suite 900Washington, DC 20006UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical agents affecting sensory organs; pharmaceutical preparations for the treatment of psoriasis; pharmaceutical preparations for the treatment of short bowel syndrome; Pharmaceutical agents for treatment of diabetes; pharmaceutical agents affecting metabolism; pharmaceutical preparations for the treatment of rheumatoid arthritis; vaccines; pharmaceutical preparations for the treatment of anemia; fungicides; anti-inflammatories; pharmaceutical agents affecting digestive organs; cardiovascular pharmaceutical preparations for the treatment of cardiovascular disorders; medicated candy; Pharmaceutical preparations to treat HPV type 16 and/or 18 caused Precancerous Dysplasia and Cancer; pharmaceutical preparations for the treatment of inflammatory bowel disease; Pharmaceutical preparations being pills for inflammation treatment; pharmaceutical preparations for the treatment of dwarfism; disinfectants for hygiene purposes; pharmaceutical preparations for the treatment of cervical intraepithelial neoplasia; pharmaceutical preparations for the treatment of systemic lupus erythematosus; Pharmaceutical agents for treating asthma, Pharmaceutical agents for the treatment of asthma; dermatological pharmaceutical products; antibiotic preparations; antibiotics; anti-cancer preparations; Antibody fusion protein for medical treatment in the nature of pharmaceutical preparations for the treatment of HPV type 16 and/or 18 caused Precancerous Dysplasia and Cancer; blood solvent, namely, blood plasma; pharmaceutical preparations for the treatment of neutropenia | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Genexine, Inc.
- Other trademarks owned by Genexine, Inc.
- Other trademarks owned by Genexine, Inc.
- Other trademarks owned by Genexine, Inc.
- Other trademarks in Class 005
- Similar marks named PAPITROL
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 29, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Feb 7, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 28, 2024 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Apr 24, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 1, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 1, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Mar 29, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 29, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 18, 2020 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Oct 13, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 13, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 30, 2020 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 30, 2020 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Sep 23, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 10, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 10, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 10, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 10, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 10, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 21, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 21, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 21, 2020 | ALIE | ASSIGNED TO LIE | — |
| Aug 5, 2020 | NREV | NOTICE OF REVIVAL - E-MAILED | — |
| Aug 4, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 4, 2020 | PETG | PETITION TO REVIVE-GRANTED | — |
| Aug 4, 2020 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| Jun 5, 2020 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jun 4, 2020 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| May 28, 2020 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 25, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Mar 25, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 25, 2020 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Mar 25, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 25, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 25, 2020 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Oct 26, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 5, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 5, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 20, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 19, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 11, 2019 | RFWR | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW | — |
| Aug 27, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 26, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 20, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 20, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 16, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 8, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |